NCT03497325View on ClinicalTrials.gov

Effect of Autologous Platelet-rich Plasma in Uterine Wound Healing

PHASE2CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

December 15, 2020

Study Completion Date

December 15, 2020

Conditions
Cesarean Section Complications
Interventions
DRUG

autologus platelet rich plasma

55 participant unergoing prelabor primary CS will receive intramyometrial injection of PRP after closure of uterine incision

DRUG

placebo

55 participant unergoing prelabor primary CS will receive intramyometrial injection of normal saline after closure of uterine incision

Trial Locations (1)

Unknown

Ain Shams university maternity hospital, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT03497325 - Effect of Autologous Platelet-rich Plasma in Uterine Wound Healing | Biotech Hunter | Biotech Hunter